Stock IGX INTELGENX TECHNOLOGIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases IntelGenx Technologies Corp. OTC Bulletin Board

Equities

IGX

US45822R1014

End-of-day quote OTC Bulletin Board
Other stock markets
- CAD - Intraday chart for IntelGenx Technologies Corp.
Apr. 08 Intelgenx Announces First Parkinson?S Disease Patients Dosed with Montelukast Versafilm® in Phase 2 ?Montpark? Clinical Trial CI
Apr. 05 IntelGenx Updates Status of Buprenorphine Buccal Film ANDA MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
GL
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
AQ
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
GL
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
GL
IntelGenx Technologies : 25 10.42pm MOCK-UP with special characters / * $ % + ` ' ' `
PU
IntelGenx Technologies : 26 10.45pm MOCK-UP with special characters / * $ % + ` ' ' `
PU
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
GL
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
GL
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
AQ
UPDATE -- IntelGenx Launches Preferred Share Regulation A Offering
GL
Studies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platform
GL
Studies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platform
AQ
IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®
GL
IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®
AQ
IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000
GL
IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000
AQ
IntelGenx Announces Changes to its Board of Directors
GL
IntelGenx Announces Changes to its Board of Directors
AQ
IntelGenx Announces Shareholder Approval of Financing Transactions
GL
IntelGenx Announces Shareholder Approval of Financing Transactions
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IGXT Stock
  4. IGX Stock
  5. News IntelGenx Technologies Corp.
  6. Press Releases